MANAGEMENT TEAM

CTCEOMag_edited_edited.jpg
DR. CHRISTOPHER TING
GROUP MD/CEO

  • Co-founder of Biomark and CEO of Innovative Diagnostics

  • Founder of Quantum Diagnostics

  • Former CEO of Quest Laboratories and Gribbles Pathology 

  • Previously Assistant Head (Biomedical Sciences Group) at the Economic Development Board of Singapore 

  • Member in Malaysia's National Key Economic Area (NKEA) Healthcare initiative

NF_edited.jpg
NABIL FAWZI
GROUP DEPUTY CEO / CFO

  • Over 18 years of corporate experience including 8 years of Corporate Finance and Mergers & Acquisitions expertise

  • Previously led EY Asia Pacific's healthcare CF/M&A space

  • Also served with PwC Singapore and UEM Group, a subsidiary of Khazanah Nasional

RR_edited.jpg
RAJKUMAR RENGARAJU
GROUP COO

  • More than 18 years of experience in the medical laboratory industry

  • Spearheaded multiple quality initiatives including CAP and ISO 15189 accreditation; and Westgard Verification

  • Led and managed multiple mergers and laboratory rollout's

ChrisSkennerton_edited_edited_edited_edited.jpg
CHRIS SKENNERTON
GROUP CTO

  • 30 years in digital innovation and transformation, operations, software engineering and lab information systems

  • Previously with 4Cyte Pathology, Healius, GE Healthcare and Royal Australian Air Force

MG_edited.jpg
MARTIN GIDDY
GROUP PMO

  • Has over 30 years of experience in medical laboratory operations, in university teaching hospitals and private laboratories

  • Previously CEO of Quantum Diagnostics and GM of Gribbles 

  • Managed the implementation of NATA and Standard Malaysia's ISO 17025 and ISO 15189 accreditations for Gribbles Pathology